Friday, 1 February 2013

nCJD


 
New Creutzfeldt-Jakob Disease
1 February 2013

                nCJD (new variant CJD) is characterised by a plaques in the brain.  This is medical speak or a small bacterial structure-my bacterial rumps!  They are foreign to the body.

                I hypothesised three years ago that a drip of interleukin 2 and 4 would produce and action the human antibody to nCJD.  I was right!

                Bacterial structures in the body which do no harm are given a minimal cell walls by the B cells as the genome his cockpit.  This system stops when there are some stand to cell damage, or the body seas the presence of even fungal antibiotics.

                Once the antibiotics and stoped, the nJCD would take off again!  But a course of the specific human antibiotic to nJCD would totally clear the bacterial structure from the body.

                This is also an idea for HIV-a viral structure that does no cell stand to cell damage.  Cell damage is a wake up call to the immune system, to make IL-2…21. IL-2&4 will initiate the immune system in just the same way.  Clearing any pathogen structure from the body.

                Plaques are also are a symptom of Alzheimer’s.  So IL-2&4 will make an action the specific human antibody.  Cause of this drug alone will clear the disease.

                Plaque structures are also clear by application of high intensity ultrasound to the affected area: 150 Watts 40 kHz ultrasound applied externally to the body.

                Parkinson’s response to either of these ideas.  There is no point in taking medication to restrict plaque growth.  Just appli this specific antibody or a course of ultrasound and the disease two parts.

                For cancer, a course of ultrasound externally to the body will clear all body and brain cancers at one course of treatment.  No drunks are required.

                Heart disease is caused by a plaques on the coronary arteries are around the kidneys.  Coronary heart disease can similarly be cleared by one application of ultrasound.

 

Jonathan Thomason       JonThm9@aol.com

No comments: